Drug Approvals
🌏 NMPA Page 4NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 37–48 of 97 articles
Innovative Oncology Pharma Companies in China: A Look Ahead
oncology · 2 min
Dr. Yuki TanakaMannKind's Pediatric Expansion: A New Era for Afrezza
diabetes · 3 min
Dr. Yuki TanakaClinical Trials Market in Oncology: Size and Growth Insights for 2034
oncology · 2 min
Dr. Yuki TanakaPREMIA and Lind Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
3 min
Dr. Yuki TanakaOnconic Therapeutics' Jakubo Enters Phase 3 Clinical Trials in China
2 min
Dr. Yuki TanakaInnovent Biologics and Pfizer: A $10.5B Oncology Partnership
oncology · 2 min
Dr. Yuki TanakaSun Pharma's USD11.75bn Acquisition of Organon: Market Analysis
3 min
Dr. Yuki TanakaMiddle East Pharma Markets: Strategic Growth at API China 2026
3 min
Dr. Yuki TanakaGlobal Drug Discovery Market to Exceed $174.92 Billion by 2035
3 min
Dr. Yuki TanakaRegulatory Strategy Reimagined: Trends Accelerating Drug Development
4 min
Dr. Yuki TanakaExosome-based Therapeutics Market Insights: 2033 Industry Report
3 min
Dr. Yuki TanakaMedical Advances Soar With APAC's Clinical Trial Growth in Oncology
oncology · 2 min
Dr. Yuki Tanaka